[1] Togni S, Maramaldi G, Bonetta A, Giacomelli L, Di Pierro F. Clinical evaluation of safety and efficacy of Boswellia-based cream for prevention of adjuvant radiotherapy skin damage in mammary carcinoma: a randomized placebo controlled trial. Eur Rev Med Pharmacol Sci. 2015; 19(8): 1338-1344.
[2] Togni S, Maramaldi G, Di Pierro F, Biondi M. A cosmeceutical formulation based on boswellic acids for the treatment of erythematous eczema and psoriasis. Clin Cosmet Investig Dermatol. 2014; 7: 321-327.
[3] Sultana A, Rahman Kh, Padmaja AR, Rahman Sh. Boswellia serrata Rox. A traditional herb with versatile pharmacological activity: a review. Int J Pharmaceut Sci Res. 2013; 4(6): 2106-2117.
[4] Badr P, Daneshamouz S, Mohammadi AA, Akbarizadeh AR, Afsharypuor S. The effect of 60Co-gamma radio-sterilization on Boswellia carterii essential oil composition. Res J Pharmacogn. 2016; 3(4): 67-74.
[5] Moussaieff A, Mechoulam R. Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials. J Pharm Pharmacol. 2009; 61(10): 1281-1293.
[6] Wichtl M. Teedrogen und phytopharmaka. 5th ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft, 2009.
[7] Acebo E, Raton JA, Sautua S, Eizaguirre X, Trebol I, Perez JLD. Allergic contact dermatitis from Boswellia serrata extract in a naturopathic cream. Contact Derm. 2004; 51(2): 91-92.
[8] Calapai G, Miroddi M, Minciullo PL, Caputi AP, Gangemi S, Schmidt RJ. Contact dermatitis as an adverse reaction to some topically used European herbal medicinal products-part 1: Achillea millefolium–Curcuma longa. Contact Derm. 2014; 71(1): 1-12.
[9] Bleasel N, Tate B, Rademaker M. Allergic contact dermatitis following exposure to essential oils. Australas J Dermatol. 2002; 43(3): 211-213.